The efficacy of statins for prevention of ischemic stroke due to blood clot is well established, but a new study in Neurology appears to possibly settle the debate over whether the drugs lower the odds of a first stroke due to intracerebral hemorrhage.

A final guidance document from FDA details the agency’s efforts to prioritize enforcement and regulatory actions for homeopathic drug products marketed in the United States. There are currently no FDA-approved products labeled as homeopathic.

Researchers of a new study published in the New England Journal of Medicine compared outcomes in pregnant patients with opioid use disorder based on whether they received opioid agonist therapy with buprenorphine as opposed to methadone.

FDA has reportedly put an OTC version of naloxone nasal spray (Narcan—Emergent BioSolutions) on the fast track to approval.

A study in BMC Medicine found that people recovering from COVID-19 are at higher risk of being newly diagnosed with diabetes.